Clinical Trial

Evaluating an Artificial Intelligence-Based Diagnostic Support Tool for Older Adults in Primary Care

Study acronym: INTERLACE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Older adults commonly experience diagnostic errors that may lead to direct harms and increased healthcare costs. Older adults are especially at risk because of higher rates of comorbidity burden, medical complexity, frailty, and cognitive impairment. An artificial intelligence (AI) clinical decision support system (CDSS) offer a promising approach to promote diagnostic excellence for older adults. The purpose of this study is to assess the acceptability and feasibility of a new AI CDSS for older adults in primary care. The goal of this AI CDSS is to provide diagnostic support during primary care visits (i.e., help make timely and accurate diagnoses) and support communication amongst patients, doctors, and caregivers about the patient's health. In this study, participants will use the AI CDSS in a primary care visit and review its suggestions for diagnoses and tests. Afterwards, they will complete a feedback survey and interview where they share their thoughts about and experience using the AI CDSS.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-09 -> 2026-11 2026-07-11
minor Completion pushed: 2026-09 -> 2026-11 2026-07-11
Trial Details
NCT Number NCT07553559
Lead Sponsor University of Pennsylvania
Collaborators: Penn Artificial Intelligence and Technology (PennAITech) Collaboratory for Healthy Aging, National Academy of Medicine (NAM)
Conditions Diagnostic Support
Enrollment 40 participants
Start Date 2026-08
Primary Completion 2026-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-07-10